When American healthcare innovation meets Indian-origin tech leadership, we see the kind of transformative impact that exemplifies the global-India connection we are passionate about at GIA. Akido’s $60M Series B funding round showcases how cross-border talent and vision can reshape industries!
What is the news?
- Akido Labs has secured $60 million in Series B funding led by Oak HC/FT with participation from Greco, SNR, Y Combinator, Future Communities Capital, Jeff Dean (Chief Scientist, Google DeepMind & Google Research), and the Comprehensive Blood & Cancer Center.
- Co-founded by Indian-American entrepreneur Prashant Samant, Akido’s ScopeAI platform is addressing the global physician shortage crisis through AI-powered clinical visits that have delivered 5x more face-to-face time with patients.
Why is it interesting?
- Akido democratizes high-quality healthcare regardless of financial means or geography.
- With a dataset of over 10 million patient case studies and a medical network of 240 providers across 26 specialities, Akido is showing how AI can scale specialized healthcare delivery while maintaining a 96 NPS score, proving that technology and empathy can go hand-in-hand.